Abstract Familial combined hyperlipidemia (FCHL) was first described as an autosomal dominant inherited trait with primary action on triglyceride levels and secondary effects on cholesterol metabolism. This conclusion has since been questioned by several groups despite subsequent supportive biochemical and metabolic studies. To reexplore the genetics of FCHL, we assembled 55 families from the United Kingdom comprising 559 persons ascertained through probands with both hypercholesterolemia and hypertriglyceridemia. The results of univariate complex segregation analysis were consistent with a major gene acting on triglyceride and explaining two thirds of the genetic variability and 20% of the phenotypic H yperlipidemia is an important risk factor for premature coronary artery disease, the commonest cause of mortality in the world. Several clearly defined genetic forms of hyperlipidemia have been identified as being due to defects in lipoprotein receptors, apolipoproteins, and enzymes of lipid metabolism, but the genetic mechanisms underlying most forms of primary hyperlipidemia are undefined.
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Abstract Familial combined hyperlipidemia (FCHL) was first described as an autosomal dominant inherited trait with primary action on triglyceride levels and secondary effects on cholesterol metabolism. This conclusion has since been questioned by several groups despite subsequent supportive biochemical and metabolic studies. To reexplore the genetics of FCHL, we assembled 55 families from the United Kingdom comprising 559 persons ascertained through probands with both hypercholesterolemia and hypertriglyceridemia. The results of univariate complex segregation analysis were consistent with a major gene acting on triglyceride and explaining two thirds of the genetic variability and 20% of the phenotypic H yperlipidemia is an important risk factor for premature coronary artery disease, the commonest cause of mortality in the world. Several clearly defined genetic forms of hyperlipidemia have been identified as being due to defects in lipoprotein receptors, apolipoproteins, and enzymes of lipid metabolism, but the genetic mechanisms underlying most forms of primary hyperlipidemia are undefined. 1 ' 2 To investigate the genetic epidemiology of primary hyperlipidemia in coronary heart disease, Goldstein et al 3 studied the families of individuals in Seattle who had survived more than 3 months after a myocardial infarction. Those in whom there was a clear predominance of elevated cholesterol or triglyceride levels were assigned to groups termed familial hypercholesterolemia and familial hypertriglyceridemia, respectively. Individuals with both elevated cholesterol and triglyceride levels were said to have familial combined hyperlipidemia (FCHL).
Goldstein et al 3 used graphical 4 and maximum-likelihood 5 methods to analyze the distribution of cholesterol and triglyceride levels within these families. Triglyceride levels were bimodally distributed in first-degree relatives above the age of 20 years. This, together with the findings that the offspring of normal subjects were unaffected and that on average fewer than one half of the offspring of affected family members were hyperlip-idemic, led the authors to conclude that FCHL is caused by the variable expression in each family of a single autosomal dominant gene with primary action on triglyceride levels and secondary action on cholesterol levels.
Although similar families have since been described by several groups 614 and FCHL has been identified as a cause of premature myocardial infarction, 15 these and other researchers 16 -19 have questioned both the coherence of FCHL and the presence of the putative dominant gene acting on triglyceride metabolism as described by Goldstein et al. 3 To clarify the genetics of combined hyperlipidemia, we assembled 55 families comprising 559 persons ascertained through a proband with combined hyperlipidemia who presented to the lipid clinic at a district general hospital. We also reexamined the original data for the pedigrees with FCHL collected in Seattle. 3 
Methods
UK Subjects
Fifty-five Caucasians of northern European origin with cholesterol levels at or above the 95th percentile (aP 95 ) and triglyceride levels >? w and at least one other living blood relative were identified. Fifty-two unrelated probands were identified from among a series of 1420 patients who attended the lipid clinic at Northwick Park Hospital (NPH), a general hospital in northwest London. A further 3 probands were identified among patients attending the lipid clinic at Hammersmith Hospital in west London. All patients had been referred by their physicians. Their lipid levels had first been measured either as part of a health screen or because of a personal or family history of atherosclerosis. Thirteen probands had coronary heart disease, of whom 9 had suffered a myocardial infarction and 1 had both peripheral vascular disease and a history of myocardial infarction. Six probands had peripheral vascular disease alone. In the remaining probands lipids were measured because of a family history of coronary vascular disease (23 individuals) or as part of a family practitioner screen (13 individuals). We excluded individuals with secondary hyperlipidemia (eg, due to hypothyroidism) (7 individuals), renal disease (1 individual), diabetes mellitus (6 patients with non-insulin-dependent diabetes and 5 with insulin-dependent diabetes), alcoholism (12 individuals with alcohol consumption greater than 21 units/wk), obesity (defined as a body mass index greater than 30 kg/m 2 ; 20 individuals), and those with a personal or family history of tendon xanthomata (25 individuals).
Blood samples for total cholesterol and triglyceride levels were drawn after a 16-hour overnight fast. Lipid analysis was by standard automated methods using commercial kits. 20 Where more than one lipid measurement had been performed in any individual (usually after detection of hyperlipidemia and subsequent clinical follow-up), the first untreated measurement obtained was used, as it was assumed to be the least biased. In the absence of published British percentile data, the "first visit" percentile points of the Lipid Research Clinics (LRC) 21 were used. Apolipoprotein (apo) B levels were not used in the selection of probands owing to inadequate standardization of assays and because insufficient epidemiological data exist to compute percentile points over a range of ages. 22 ' 23 Sixty-one percent of all first-degree relatives and spouses were tested. Of the remaining 39%, 26% were deceased, 4% refused testing, 4% could not be traced, 3% lived outside Europe, 1% were aged less than 6 years, and 1% were pregnant during the screening procedure. Fifty-five percent of all second-degree relatives were tested. Of the remaining 45%, 4% were deceased, 2% refused testing, 23% could not be traced, 9% lived outside Europe, and 6% were aged less than 6 years (all percentages have been rounded to the nearest whole number). In addition, one second-degree relative was pregnant during the screening period and was excluded.
The pedigrees of the families of the 55 probands are shown in the Figure. There were no consanguineous matings in these families. Tables of lipid levels and ages have been submitted to the journal and are available from the authors on request.
US Subjects
Goldstein et al 3 studied the families of 500 individuals in Seattle who had survived more than 3 months after a myocardial infarction. Percentile points for cholesterol and triglyceride levels were calculated by using a sample of 950 nonblood relatives of the probands. Of these 500, 131 had at least one lipid level >P 92 5 for their age and sex or were taking clofibrate, a lipid-lowering drug, and had more than three available first-degree relatives. The families of these 131 individuals were divided into two groups depending on whether or not a first-degree relative of the proband had hyperlipidemia, which was defined as £P99 for individuals 20 years of age or older and >P 95 for younger individuals. Hyperlipidemic first-degree relatives existed in 86 pedigrees; these were divided into three groups. Those in whom there was a clear predominance of elevated cholesterol or triglyceride levels were assigned to groups termed familial hypercholesterolemia or familial hypertriglyceridemia, respectively. This left 47 pedigrees with both cholesterol and triglyceride levels &P90. These were said to have FCHL. The data for these 47 families were kindly made available by Prof Goldstein.
Statistical Analysis Preliminary Analysis
Triglyceride levels were transformed natural logarithm values to remove extreme positive skewness. Cholesterol levels were not transformed, as they were approximately normally distributed. Levels were adjusted to age 40 years and male sex by multiple linear regression by using the computer statistical package MINITAB. Data for all family members were included in the regression analysis, as no suitable control population data were available. Age 40 years was chosen, as it was close to the mean age for the NPH sample and because it is the age at which sex differences in lipids are at a minimum. Significant independent predictors (P<.01) were selected by a stepwise maximum F statistic criterion (STEPWISE procedure in MINITAB), which implements a forward-selection algorithmic search procedure. Terms were added sequentially to the model until further additions did not improve the fit. At each stage the term that gave the greatest improvement of fit was selected. The following list of terms was selected from: age (years), age 2 (years 2 ), sex (coded 1 for males, 2 for females), sex x age, and sex x age 2 . Thus linear, quadratic, and interactive sex and age effects were included, which is important because of the well-established epidemiological data showing significant age and sex effects on lipid levels. 21 The final models are shown in "Results." 
Complex Segregation Analysis
Complex segregation analysis was performed by using the PAP (PEDIGREE ANALYSIS PACKAGE, revision 3.0) computer programs, 24 which fit a variety of genetic and nongenetic models, in an attempt to explain the variability of age-and sex-adjusted lipid levels in our families. The general (or unified) model 25 extends the mixed model, 26 which partitions the overall variance into three independent additive components (a major gene effect, polygenes, and random individualspecific nongenetic effects) by incorporating transmission probabilities. This extension permits formal testing of mendelian segregation proportions, which reduces false claims of detecting a major gene model. A bivariate analysis in which cholesterol and loge triglyceride levels were jointly analyzed and two univariate analyses in which cholesterol and loge triglyceride levels were separately analyzed were performed. Two factors were specified (which, for a major gene, are equivalent to alleles), one factor for low (I) and the other for high (h) levels of each lipid. Combinations of the two factors form three ousiotypes, ///, l/h, and hlh, 21 which are equivalent to genotypes when modeling a major gene. The mean lipid level for each ousiotype was denoted by jit,, fa, and /x 3 . Each mean was associated with a within-ousiotype variance (cr 2 , ie, homoscedasticity was assumed) that was partitioned into random nongenetic and polygenic components. The fraction of the within-ousiotype variance (a 2 ) attributed to polygenes is termed the polygenic heritability (h 2 ). The polygenic component for large pedigrees is necessarily approximated. 28 The frequencies of the low and high factors are given by p and 1-p, respectively. Hardy-Weinberg equilibrium was assumed when computing the frequencies of ousiotypes from the factor frequencies.
Transmission of factors from parents to offspring was modeled by three transmission probabilities (T,, T 2 , and T 3 ). 29 The probabilities of a parent with ousiotype ///, l/h, or hlh transmitting a factor 1 to a child are T, , T 2 , and T 3 , respectively. For a major gene, T, = 1.0, T 2 =0.5, and T 3 =0.0 fulfills mendelian expectations. Allowing the three transmission probabilities to vary freely in the general model eliminates a potential bias toward selecting a major gene model. Ascertainment was corrected for by dividing the likelihood of each complete pedigree (which includes all available data for every family member including the proband) by the likelihood of the subset of the pedigree that led to its collection. 30 For the NPH analysis, each pedigree was principally ascertained through a single individual with combined hyperlipidemia, so lipid levels for this individual alone were included in a "dummy" nuclear family that was used to compute the relevant likelihood for ascertainment correction. Lipids were measured in some probands because of a family or personal history of coronary heart and/or peripheral vascular disease; no correction was made for these latter potential ascertainment biases. We also performed segregation analysis on the 47 pedigrees described by Goldstein et al 3 as having FCHL. To allow for the two-stage method of ascertainment in the Seattle pedigrees, data for both the primary proband (who had survived at least 3 months after myocardial infarction) and a randomly chosen hyperlipidemic first-degree relative were identified before segregation analysis and constituted the ascertainment-correction "dummy" family.
Segregation analysis of quantitative traits assumes normality, and skewed data may mimic segregation of a major genetic component.
3133 Skewness can be eliminated by transforming the data, but this may reduce the power to detect a major genetic effect if one exists.
34
- 35 Apart from partial correction of the extreme skewness in triglyceride levels by taking natural logarithms, we chose not to further normalize the data before segregation analysis.
Pairs of models were evaluated with likelihood-ratio tests. The most complex model (with the maximum number of parameters) was initially fitted, and submodels (with fewer parameters) were then compared; differences in -2xlog«. likelihood were approximated by a x 2 distribution with degrees of freedom equal to the difference in the number of parameters fitted in each model. The most favorable model was taken to be the model with the smallest number of parameters that was not rejected when compared with the general model. Models were also compared by using Akaike's Information Criterion (AIC), which specifies the best-fitting model as that with the minimum AIC (AIC=-2xlog e likelihood+twice the number of estimated parameters). 36 Maximum-likelihood estimates of parameters were solved iteratively. 37 We chose to fit multimodal models under the constraint
Results
Preliminary Statistical Analysis
The structures of the pedigrees included in this study are shown in the Figure. For the NPH families, cholesterol was adjusted for age (years) and age 2 (years 2 ) terms [cholesterol in milligrams per deciliter=123 + (3.68xage)-(0.02xage
2 )], which explained 28% of the total variability of cholesterol levels in this sample. Loge triglyceride levels were adjusted for age and sex terms [loge triglyceride in milligrams per deciliter=4.68+ (0.0144xage)-(0.26xsex)], which explained 17% of the total variance. For the Seattle families, cholesterol was adjusted for age (years) and age 2 (years 2 ) terms [cholesterol in milligrams per deciliter= 145 +(3.08 x age) -(0.0175 x age
2 )], which explained 33% of the total variance. Log. triglyceride levels were adjusted for age (years) and age 2 x sex terms [log. triglyceride in milligrams per deciliter=3.75 + (0.0271 x age) -(0.000076 x age 2 x sex)], which explained 30% of the total variance. Table 1 shows the levels of lipids in NPH family members stratified by their relation to the probands; the LRC levels for a 40-year-old man are also shown for comparison. The distributions of cholesterol and loge triglyceride levels in the spouses of family members and the LRC data were comparable. Both first-and seconddegree relatives were significantly (P<.001) hyperlipid- Results of complex segregation analysis of total cholesterol levels in 55 Northwick Park pedigrees using the PAP program package. 24 p indicates the frequency of the factor associated with low lipid levels; T, , T 2 , and T 3 , transmission probabilities for the low/low, low/high, and high/high ousiotypes, respectively; M L M2. and ^3. means of the three modeled distributions; a, SD associated with each distribution; h 2 , polygenic heritability; -2xl_og e likelihood, -2 times the natural logarithm of the likelihood of each model; Var, parameters being fitted; AIC, Akaike's Information Criterion (defined as the difference in -2 x l o g e likelihood between the models to be compared plus twice the number of estimated parameters 36 ); and P, level of statistical significance based on x 2 -Fixed parameters are shown in parentheses. The most favorable model (with the smallest AIC) is shown in boldface type.
*ln the general model T, and T 3 fixed during iteration at the limits shown.
emic compared with the spouses. Levels of both lipids were significantly (/ ) <.001) negatively correlated between NPH spouses (cholesterol, p= -.31; loge triglyceride, p=-.34). Neither cholesterol (P=.153) nor triglyceride (P=.259) was significantly correlated between spouses in the Seattle sample.
Univariate Segregation Analysis
The results of the univariate segregation analyses are shown in Tables 2 through 5 . For cholesterol levels in the NPH dataset (Table 2) , the mixed T 2 model, which fitted with a nonmendelian transmission probability, was not rejected when compared with the general model (xi = 0, P=1.0) and was selected as the most favorable model. The Seattle dataset (Table 3 ) also lacked support for a major gene component for cholesterol levels, and the most favorable model (the general model) fitted with nonmendelian transmission probabilities. With the exception of the T 2 model for the NPH data (xl=T, P=.O7), all other models in both datasets were rejected when compared with the general model (P<.05).
For log c triglyceride levels in the NPH dataset, the most favorable model (T 2 ; Table 4 ) fitted with a common allele (q=0.25) of modest effect, being passed on at a near-mendelian transmission frequency (T 2 =0.32; 95% confidence interval, 0.16 to 0.48). In the NPH families, the mean of the high distribution, /x 3 , was 1.2 SDs above the central mean, fj^. The T 2 mixed model, which included the polygenic component h 2 , was also not rejected when compared with the general model 0^=3, P=.22), but it did not fit significantly better than the T 2 model (xl=2, P=A6), indicating the absence of an independent polygenic component. In the Seattle families (Table 5 ) the mixed model was selected as the most favorable model by using AIC; four other models were not rejected when compared with the general model (ie, major gene, x 2 , T 2 mixed, and mixed environmental models). The major effect on triglyceride appeared to be carried by a relatively rare allele (q=0.05) of appre- Results of segregation analysis of total cholesterol levels in 47 Seattle pedigrees. 3 For explanation of symbols see Table 2 . *ln the general model p fixed during iteration at the limit shown. Results of segregation analysis of triglyceride levels in 55 Northwick Park pedigrees. For explanation of symbols see Table 2 .
ciable effect, the mean of the high distribution ju 3 , being 5 SDs above the central mean ix 2 .
In both the NPH and Seattle datasets there was relatively little separation between the means of the lower and intermediate triglyceride distributions (^i, and /x 2 ) compared with the separation between the means of the intermediate and higher distributions (ju, 2 and /i 3 ), suggesting a recessive pattern of inheritance for this lipid.
In both the Seattle and NPH datasets there was a marked familial resemblance in cholesterol and triglyceride levels. As a reflection of this, models with a genetic component (eg, polygenic or major gene) fitted significantly better than the sporadic model in all cases. In both samples there was support for a major effect acting on cholesterol and triglyceride levels (ie, multimodal models generally fitted substantially better than unimodal models). This is consistent with the observed skewness in the distributions of these lipids.
Bivariate Segregation Analysis
The results from bivariate analysis of cholesterol and loge triglyceride levels in the NPH and Seattle datasets are shown in Tables 6 and 7 , respectively. In the NPH dataset the mixed environmental model was not rejected when compared with the general model (^3=5,
P=.\l).
In both these models the polygenic component (h 2 ) was fixed at an arbitrary high value (0.75) to avoid the numerical problems that were encountered when h 2 was allowed to vary freely. Models that incorporated a major gene component (mixed and major gene models) were clearly rejected (^,=58, P<<.001 and ^5=91, P«.001, respectively).
In the Seattle dataset all submodels were rejected when compared with the general model, which fitted with nonmendelian transmission probabilities. For example, models that included a major gene component (mixed and major gene models) were clearly rejected (#3=91, P<<. 001 and ^5=H8,/ 5 <<001, respectively).
Discussion
The purpose of this investigation was to clarify the role of genetic factors in the origins of combined hyperlipidemia. Our objectives were to determine if the familial clustering of combined hyperlipidemia was consistent with a genetic model and, if so, whether major gene and polygenic models could be distinguished. The finding of a major genetic influence would permit us to design a linkage project that could be used to identify causal genes for this condition. In our study we used complex segregation analysis to study 55 British pedigrees with combined hyperlipidemia. We also reevalu- Results of segregation analysis of triglyceride levels in 47 Seattle pedigrees. 3 It was impossible to improve the fit of either the mixed r 2 model or the general model, as the parameters tended to fix at those of the mixed model. For explanation of symbols see Table 2 .
by guest on October 15, 2017 http://atvb.ahajournals.org/ Downloaded from ated the original pedigrees of Goldstein and colleagues. 3 The results of our complex segregation analysis are largely in agreement with the conclusions of Goldstein et al, in that we found a major genetic effect on triglyceride levels but did not detect this effect on cholesterol levels. This result is consistent with a major gene in each family with a primary action on triglyceride levels and a secondary action on cholesterol levels. Thus, in pedigrees collected by different criteria and in different parts of the world and by using a different mode of analysis, we confirm the original genetic analysis of FCHL.
In the univariate analysis of both cholesterol and triglyceride levels, the sporadic model was overwhelmingly rejected, indicating that there is a strong familial resemblance for both these lipids in our families. The inheritance of cholesterol levels is consistent with a polygenic trait (ie, the most favorable model, the general model, fitted with h 2 =0.29). Analysis most favored a T 2 model to explain the inheritance of triglyceride levels, with T 2 fixing at 0.32 (95% confidence interval, 0.16 to 0.48), with little support for a significant polygenic component.
The finding of a nonmendelian intermediate transmission probability in this latter model cannot be interpreted simply. Unfortunately, lipid levels were unavailable from the substantial fraction (26%) of first-degree relatives who were deceased; we suspect that this missing data may have confounded our attempts to resolve a genetic model to explain the evident familial clustering.
An alternative hypothesis to explain the evidence of familial clustering and rejection of both major-gene and polygenic models would require consideration of shared family environment. In the NPH families there was significant negative correlation between the spouses for both lipid levels. The lack of similarity of lipid levels between spouses is consistent with genetically determined hyperlipidemia being present in the biological relatives of the probands but absent in their spouses.
We also carried out complex segregation analysis on the original Seattle pedigrees described by Goldstein et al 3 and on which the original description of FCHL was based. In the Seattle cohort univariate complex segregation analysis confirmed the conclusions of Goldstein et al, in that striking familial clustering of both hypercholesterolemia and hypertriglyceridemia was found and that a major gene component was found to influence triglyceride levels.
The results from bivariate segregation analysis for our 55 families and the Seattle cohort were similar, inasmuch as all submodels were rejected when compared with the general model, which, when fitted with transmission probabilities, markedly deviated from mendelian expectation. There was highly significant evidence of familial resemblance for lipid levels for both cohorts. It appears that the concept of a single gene that jointly influences cholesterol and triglyceride levels is unlikely and that the evidence for a major gene influencing triglyceride levels was masked in the bivariate analysis.
In assessing the validity of our conclusions from this study, several factors must be considered. First, failure to allow for skewness, polygenes, and shared family environment can give spurious evidence for a major gene where none is present. 38 We elected to analyze the data without transformation to remove skewness completely, as this procedure has been reported to reduce the power of mixed-model analysis to detect a major gene effect. 34 - 35 PAP incorporates an approximate allowance for a polygenic component in the likelihood calculations. 28 We made no correction for shared familial environment in our analysis.
Second, inadequate correction for potential sources of ascertainment bias can also provide misleading results, suggesting the presence of a major gene when one is absent. 38 Inevitably, in a series such as the NPH pedigrees, which were not collected as part of a random population survey, there is the danger of unwittingly introducing ascertainment bias. Thus, although no proband was selected because he or she had a relative who was known a priori to be hyperlipidemic, some probands presented as a consequence of their relatives' premature cardiovascular disease, and as such their relatives are more likely to be hyperlipidemic.
In considering the ascertainment of the NPH and Seattle series several differences in the sampling procedure are apparent. The Seattle families were ascertained through survivors of myocardial infarction, whereas the NPH families were identified through probands presenting to a lipid outpatient clinic with combined hyperlipidemia. The Seattle families were assembled if the proband had more than three living first-degree relatives, whereas the NPH families were only required to have at least one living first-degree relative. In addition, in the Seattle series pedigrees were ascertained based on probands with at least one lipid level >P 9 2. 5 for their age and sex and the presence of familial hyperlipidemia, defined as sPgg for individuals of 20 years of age or older and >P 95 for younger individuals. Those pedigrees with both cholesterol and triglyceride levels &P90 defined the diagnostic entity of FCHL. In contrast, our pedigrees were identified through a scheme in which probands had cholesterol levels >P 95 and triglyceride levels SP90 (at first measurement). Therefore, before complex segregation analysis, we attempted to correct for the two-stage method of ascertainment in the Seattle pedigrees.
Third, one quarter of the first-degree relatives were deceased at the time of sampling, which is certain to have had a major effect on subsequent segregation analysis, especially if a large proportion of the deaths can be attributed to cardiovascular disease and atherosclerosis. In the NPH series of families the median age of the probands was 55 years. Frequently only one parent of the proband was available for testing, and the parents as a group were fairly normolipidemic. More marked hyperlipidemia may have been more prevalent among the deceased parents, which would systematically tend to confound attempts to resolve a genetic model. We suspect that this may have resulted in the rejection of the mixed model when investigating the inheritance of triglyceride levels in our families and note that the intermediate transmission probability for the T 2 model (0.32) was fairly close to mendelian expectation (0.5).
Fourth, by analyzing pooled families from each population we made the assumption that a single underlying genetic mechanism is responsible for hyperlipidemia in all the families. Although this allows for locus heterogeneity to produce the same phenotype in different families, the alternative, that there is a spectrum of Results of bivariate complex segregation analysis of total cholesterol and triglyceride levels in 55 Northwick Park pedigrees using the PAP program package. 24 For explanation of symbols see Table 2 .
genetic mechanisms (eg, some families are polygenic and some are monogenic), would require separate analysis of each family, which is impractical, as the individual families in both datasets are relatively small and contain insufficient data to be able to resolve the alternative models. Fifth, a useful but not absolute criterion for the detection of major gene effects in the inheritance of continuous traits is the presence of bimodality of that trait, provided that the major gene effect is sufficient to produce discernible separation of the means of the two trait distributions in the pedigrees under study. 39 In their original analysis Goldstein et al 3 used graphical 4 and maximum-likelihood 5 methods to analyze the distribution of cholesterol and triglyceride levels in their families, methods that were not able to explicitly allow for a skewness component. They concluded that triglyceride but not cholesterol levels were bimodally distributed in relatives above 20 years of age. We used the computer program SKUMIX, 34 in which multimodal or single normal distributions were fitted to the age-and sex-adjusted distributions of cholesterol and log,, triglyceride levels (data not shown). The program incorporates an option to fit a single skewed distribution. Using SKUMIX, we failed to detect evidence for bimodality in triglyceride or cholesterol levels in either set of families, which were adequately fitted by a single, modestly skewed distribution. We suspect that the discrepancy between the analysis by Goldstein et al and our retrospective analysis of the Seattle data is a consequence of the use of different statistical methods (ie, a skewness parameter is solely implemented in SKUMIX). Ott 40 has shown by computer simulation that the very procedure of assigning pedigrees by strategies similar to that employed by Goldstein et al can produce some degree of bimodality. In the Seattle study the pedigrees were assigned to groups depending on whether the pedigree contained at least one relative besides the proband whose lipid level >P W for subjects over 20 years and >P 95 for subjects less than 20 years. Notwithstanding this difference, our complex segregation analysis is in broad agreement with the major conclusions of Goldstein and colleagues.
With each of the above caveats, final proof of a major gene effect must come from the identification of susceptibility loci in linkage or other genetic studies. It seems most probable from the previous work of Goldstein et al 3 and from the present study that this major gene Results of bivariate complex segregation analysis of total cholesterol and triglyceride levels in 47 Seattle pedigrees 3 using the PAP program package. 24 For explanation of symbols see Table 2 . *ln the general model p and T 2 fixed during iteration at the limits shown. <.001
effect will be one that acts predominantly on triglyceride metabolism. Lipoprotein turnover studies with conventional and stable isotopes suggest that this genetic influence leads to overproduction of triglyceride-rich very-low-density lipoprotein from the liver. 4144 In addition, previous studies indicate that a number of other genes may exacerbate the FCHL phenotype. Low activity and mass of lipoprotein lipase have been described in FCHL subjects, and heterozygotes deficient for this enzyme demonstrate a mild combined hyperlipidemia phenotype. 45 Alleles of the apoA-I/C-III/A-IV gene cluster on human chromosome l l q are associated with a mixed hyperlipidemia phenotype. 4650 Although one attempt to replicate these results has been unsuccessful, 51 the weight of evidence suggests that alleles at the apoA-I/C-III/A-IV locus make FCHL worse. Some persons with combined hyperlipidemia appear to have insulin resistance, and it seems probable that this relatively common metabolic abnormality may also worsen the hyperlipidemia of FCHL. 49 ' 52 In addition, a major gene that confers LDL-sized subclass patterns appears to have an allele that confers high triglyceride levels on those with FCHL. 53 LDL subclass patterns have been provisionally linked to several different loci, including the LDL receptor and insulin receptor loci on chromosome 19, the apoA-I/C-III/A-IV gene cluster, and the ; however, these results have not been confirmed by all groups. 55 Overall, these results suggest that a number of different loci may affect the expression of the FCHL phenotype but that additional major genes have still to be identified.
It is important to consider the implications of this segregation analysis for mapping the putative major gene that influences serum triglyceride levels in families. Carey and Williamson 56 estimate that in a sample of 260 sibling pairs in which the proband was ascertained with a triglyceride level >P 95 there would be an 80% chance of detecting linkage to a fully informative marker tightly linked (0=0.05) to a major locus (with an additive mode of inheritance and gene frequency of 0.2) that would determine 20% of the total phenotypic variance in a quantitative trait. Only 73 sibling pairs would be needed if the trait showed a recessive pattern of inheritance. With these example power calculations as a guide, we estimate that about 150 sibling pairs would be required to have a good chance (power=80%) of mapping the major gene identified in the NPH set of families. These calculations are based on the assumption that the major gene effect is homogeneous; genetic heterogeneity would necessitate substantially larger family samples. We are currently assembling an ex- 
